167 related articles for article (PubMed ID: 16850522)
1. Plasma concentrations of high-dose olanzapine in a double-blind crossover study.
Kelly DL; Richardson CM; Yu Y; Conley RR
Hum Psychopharmacol; 2006 Aug; 21(6):393-8. PubMed ID: 16850522
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia.
Kelly DL; Conley RR; Richardson CM; Tamminga CA; Carpenter WT
Ann Clin Psychiatry; 2003; 15(3-4):181-6. PubMed ID: 14971863
[TBL] [Abstract][Full Text] [Related]
3. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients.
Bergemann N; Frick A; Parzer P; Kopitz J
Pharmacopsychiatry; 2004 Mar; 37(2):63-8. PubMed ID: 15048613
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study.
Conley RR; Kelly DL; Richardson CM; Tamminga CA; Carpenter WT
J Clin Psychopharmacol; 2003 Dec; 23(6):668-71. PubMed ID: 14624201
[No Abstract] [Full Text] [Related]
6. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.
Spina E; D'Arrigo C; Migliardi G; Santoro V; Muscatello MR; Micò U; D'Amico G; Perucca E
Ther Drug Monit; 2006 Oct; 28(5):599-602. PubMed ID: 17038872
[TBL] [Abstract][Full Text] [Related]
7. Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.
Zoccali R; Muscatello MR; Torre DL; Malara G; Canale A; Crucitti D; D'Arrigo C; Spina E
Pharmacol Res; 2003 Oct; 48(4):411-4. PubMed ID: 12902213
[TBL] [Abstract][Full Text] [Related]
8. Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.
Kluge M; Schuld A; Himmerich H; Dalal M; Schacht A; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T
J Clin Psychopharmacol; 2007 Dec; 27(6):662-6. PubMed ID: 18004133
[TBL] [Abstract][Full Text] [Related]
9. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
10. Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine.
Alfaro CL; Wudarsky M; Nicolson R; Gochman P; Sporn A; Lenane M; Rapoport JL
J Child Adolesc Psychopharmacol; 2002; 12(2):83-91. PubMed ID: 12188977
[TBL] [Abstract][Full Text] [Related]
11. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?
Eschweiler GW; Bartels M; Längle G; Wild B; Gaertner I; Nickola M
Pharmacopsychiatry; 2002 May; 35(3):96-100. PubMed ID: 12107853
[TBL] [Abstract][Full Text] [Related]
12. Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study.
Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; DeThomas C; Cullen K; Regan J; Kane JM
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):307-16. PubMed ID: 18759640
[TBL] [Abstract][Full Text] [Related]
13. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.
Naber D; Riedel M; Klimke A; Vorbach EU; Lambert M; Kühn KU; Bender S; Bandelow B; Lemmer W; Moritz S; Dittmann RW
Acta Psychiatr Scand; 2005 Feb; 111(2):106-15. PubMed ID: 15667429
[TBL] [Abstract][Full Text] [Related]
14. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
15. Plasma clozapine concentration coefficients of variation in a long-term study.
Diaz FJ; de Leon J; Josiassen RC; Cooper TB; Simpson GM
Schizophr Res; 2005 Jan; 72(2-3):131-5. PubMed ID: 15560958
[TBL] [Abstract][Full Text] [Related]
16. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
[TBL] [Abstract][Full Text] [Related]
17. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
18. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.
Melkersson KI; Dahl ML
Psychopharmacology (Berl); 2003 Nov; 170(2):157-66. PubMed ID: 12851739
[TBL] [Abstract][Full Text] [Related]
19. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.
Potkin SG; Bera R; Gulasekaram B; Costa J; Hayes S; Jin Y; Richmond G; Carreon D; Sitanggan K; Gerber B
J Clin Psychiatry; 1994 Sep; 55 Suppl B():133-6. PubMed ID: 7961557
[TBL] [Abstract][Full Text] [Related]
20. Effects of age and sex on olanzapine plasma concentrations.
Weiss U; Marksteiner J; Kemmler G; Saria A; Aichhorn W
J Clin Psychopharmacol; 2005 Dec; 25(6):570-4. PubMed ID: 16282840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
